Immune checkpoint inhibitors and cardiovascular toxicity.

Lyon AR, Yousaf N, Battisti NML, Moslehi J, Larkin J
Lancet Oncol. 2018 19 (9): e447-e458

PMID: 30191849 · DOI:10.1016/S1470-2045(18)30457-1

MeSH Terms (9)

Antineoplastic Agents, Immunological Cardiotoxicity Heart Heart Diseases Humans Neoplasms Risk Assessment Risk Factors Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities:

Links